Dimensional Fund Advisors LP Increases Stake in GE HealthCare Technologies Inc. $GEHC

Dimensional Fund Advisors LP boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.0% in the 1st quarter, HoldingsChannel reports. The fund owned 5,399,439 shares of the company’s stock after acquiring an additional 105,995 shares during the period. Dimensional Fund Advisors LP’s holdings in GE HealthCare Technologies were worth $384,219,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Auto Owners Insurance Co boosted its holdings in GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Norges Bank purchased a new position in GE HealthCare Technologies during the 4th quarter worth $596,024,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter worth about $533,655,000. Cynosure Group LLC grew its stake in shares of GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock valued at $358,055,000 after purchasing an additional 4,344,817 shares during the last quarter. Finally, Boston Partners purchased a new position in GE HealthCare Technologies in the 3rd quarter valued at $287,627,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. BMO Capital Markets began coverage on GE HealthCare Technologies in a report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective on the stock. Jefferies Financial Group lowered their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. UBS Group dropped their price target on GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating for the company in a research report on Thursday, July 16th. Piper Sandler lowered their price target on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Finally, Oppenheimer reiterated an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $76.41.

Insiders Place Their Bets

In related news, CEO Peter J. Arduini acquired 4,169 shares of GE HealthCare Technologies stock in a transaction on Thursday, April 30th. The shares were purchased at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at $15,544,686.08. The trade was a 1.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Frank R. Jimenez purchased 1,750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the completion of the purchase, the insider directly owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This represents a 1.90% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have acquired 21,847 shares of company stock valued at $1,361,355. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $62.04 on Wednesday. The company’s fifty day simple moving average is $63.66 and its 200-day simple moving average is $71.60. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a market cap of $28.22 billion, a PE ratio of 14.84, a P/E/G ratio of 1.71 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.